Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus

Citation
P. Derkinderen et al., Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus, J NEUROCHEM, 77(3), 2001, pp. 957-960
Citations number
31
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROCHEMISTRY
ISSN journal
00223042 → ACNP
Volume
77
Issue
3
Year of publication
2001
Pages
957 - 960
Database
ISI
SICI code
0022-3042(200105)77:3<957:CAPMPK>2.0.ZU;2-U
Abstract
Cannabinoid receptors (CBI-R) are the target of a novel class of neuromodul ators, the endocannabinoids. Yet, their signalling mechanisms in adult brai n are poorly understood. We report that, in rat and mouse hippocampal slice s, anandamide and 2-arachidonoylglycerol, synthetic cannabinoids, and Delta (9)-tetrahydrocannabinol activated p38 mitogen-activated protein kinases ( MAPK), but not c-Jun N-terminal kinase (JNK). In contrast, lysophosphatidic acid (LPA), a lipid messenger acting on different receptors, increased bot h p38-MAPK and JNK phosphorylation. The effects of cannabinoids on p38-MAPK were mediated through activation of CB1-R because they were blocked in the presence of SR 141716 A and absent in CB1-R knockout mice, two conditions that did not alter the effects of LPA. The activation of p38-MAPK by cannab inoids was insensitive to inhibitors of Src. These results provide new insi ghts into the cellular mechanisms by which cannabinoids exert their effects in hippocampus.